SBNO2 Is a Critical Mediator of STAT3-Driven Hematological Malignancies

To understand the consequences and molecular mechanisms contributing to disease development and oncogenic transformation, investigators developed murine hematopoietic stem and progenitor cell models expressing mutated STAT3Y640F.